News
TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
"Does she have any flaws at all?" My business partner asked aloud, after we had just finished interviewing a strong candidate ...
LONG BEACH, Calif. -- Outcomes in neovascular age-related macular degeneration (nAMD) failed to improve with the addition of ...
LONG BEACH, Calif. -- Concomitant treatment with drugs for geographic atrophy (GA) and neovascular macular degeneration (nAMD ...
In what's known as embryo adoption, Lindsey and Tim Pierce used a handful of donated embryos that have been frozen since 1994 ...
Multiple healthcare organizations that have historically helped the CDC's Advisory Committee on Immunization Practices (ACIP) ...
For clinicians managing PTLDS, the CDC released a toolkit in 2024 and the American Medical Association launched a continuing ...
Could endocrine therapy plus a CDK4/6 inhibitor offer a viable chemo-sparing option in hormone receptor (HR)-positive/HER2-positive breast cancer?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results